The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy

Overview of attention for article published in Arthritis Research & Therapy, January 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Analyzing the risk of osteoporosis and fracture in rheumatoid arthritis patients who have been treated with various biologics

Article in International Journal of Rheumatic Diseases (February 2024)

Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System

Article in RMD Open (October 2023)

Patterns in the Sequential Treatment of Patients With Rheumatoid Arthritis Starting a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug: 10‐Year Experience From a US‐Based Registry

Article in ACR Open Rheumatology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.